Intellectual Property partner Lisa Ferri (New York) and Litigation & Dispute Resolution partner Christopher Mikson (Washington DC) are quoted in this article discussing uncertainty surrounding Affordable Care Act provisions for licensing biosimilar products.
Downloads –
Related Capabilities
Industries –
News
-
March 182019
-
March 082019
-
February 212019
Stay up-to-date on our perspectives
Subscribe to Email